BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 26690492)

  • 1. Discovery of a Natural Defense Against HIV With Therapeutic Potential.
    Poveda E
    AIDS Rev; 2015; 17(4):238. PubMed ID: 26690492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mitochondrial translocator protein, TSPO, inhibits HIV-1 envelope glycoprotein biosynthesis via the endoplasmic reticulum-associated protein degradation pathway.
    Zhou T; Dang Y; Zheng YH
    J Virol; 2014 Mar; 88(6):3474-84. PubMed ID: 24403586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERManI (Endoplasmic Reticulum Class I α-Mannosidase) Is Required for HIV-1 Envelope Glycoprotein Degradation via Endoplasmic Reticulum-associated Protein Degradation Pathway.
    Zhou T; Frabutt DA; Moremen KW; Zheng YH
    J Biol Chem; 2015 Sep; 290(36):22184-92. PubMed ID: 26205822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
    Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
    J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
    Blanco J; Barretina J; Clotet B; Esté JA
    J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HIV-1 Env protein signal sequence retards its cleavage and down-regulates the glycoprotein folding.
    Li Y; Luo L; Thomas DY; Kang CY
    Virology; 2000 Jul; 272(2):417-28. PubMed ID: 10873786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis.
    Yao Q; Compans RW; Chen C
    Virology; 2001 Jun; 285(1):128-37. PubMed ID: 11414813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cells transfected with a non-neutralizing antibody gene are resistant to HIV infection: targeting the endoplasmic reticulum and trans-Golgi network.
    Zhou P; Goldstein S; Devadas K; Tewari D; Notkins AL
    J Immunol; 1998 Feb; 160(3):1489-96. PubMed ID: 9570571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the CD4 receptor versus HIV coreceptors in envelope-mediated apoptosis in peripheral blood mononuclear cells.
    Arthos J; Cicala C; Selig SM; White AA; Ravindranath HM; Van Ryk D; Steenbeke TD; Machado E; Khazanie P; Hanback MS; Hanback DB; Rabin RL; Fauci AS
    Virology; 2002 Jan; 292(1):98-106. PubMed ID: 11878912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
    Xiao X; Kinter A; Broder CC; Dimitrov DS
    Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Vpr increases Env expression by preventing Env from endoplasmic reticulum-associated protein degradation (ERAD).
    Zhang X; Zhou T; Frabutt DA; Zheng YH
    Virology; 2016 Sep; 496():194-202. PubMed ID: 27343732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum.
    Buonocore L; Rose JK
    Nature; 1990 Jun; 345(6276):625-8. PubMed ID: 2190096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV and SIV gp120 binding does not predict coreceptor function.
    Baik SS; Doms RW; Doranz BJ
    Virology; 1999 Jul; 259(2):267-73. PubMed ID: 10388651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stoichiometric parameters of HIV-1 entry.
    Zarr M; Siliciano R
    Virology; 2015 Jan; 474():1-9. PubMed ID: 25463598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization.
    Hu Q; Napier KB; Trent JO; Wang Z; Taylor S; Griffin GE; Peiper SC; Shattock RJ
    J Mol Biol; 2005 Jul; 350(4):699-712. PubMed ID: 15964018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tyrosine kinase activation blocks the down-regulation of CXC chemokine receptor 4 by HIV-1 gp120 in CD4+ T cells.
    Su SB; Gong W; Grimm M; Utsunomiya I; Sargeant R; Oppenheim JJ; Ming Wang J
    J Immunol; 1999 Jun; 162(12):7128-32. PubMed ID: 10358157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genetically engineered spleen necrosis virus-derived retroviral vector that displays the HIV type 1 glycoprotein 120 envelope peptide.
    Jiang A; Fisher H; Pomerantz RJ; Dornburg R
    Hum Gene Ther; 1999 Nov; 10(16):2627-36. PubMed ID: 10566890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HIV-1 Gp120/CXCR4 axis promotes CCR7 ligand-dependent CD4 T cell migration: CCR7 homo- and CCR7/CXCR4 hetero-oligomer formation as a possible mechanism for up-regulation of functional CCR7.
    Hayasaka H; Kobayashi D; Yoshimura H; Nakayama EE; Shioda T; Miyasaka M
    PLoS One; 2015; 10(2):e0117454. PubMed ID: 25688986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.